Jeff E Borenstein
Overview
Explore the profile of Jeff E Borenstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
200
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Borenstein J, Dean B, Leifke E, Korner P, Yonkers K
J Womens Health (Larchmt)
. 2007 Oct;
16(8):1139-44.
PMID: 17937566
Background: In studies of premenstrual syndrome (PMS), a significant response to treatment is commonly defined as a 50% reduction in symptom scores, but empirical support for this definition is lacking....
2.
Borenstein J, Dean B, Yonkers K, Endicott J
Obstet Gynecol
. 2007 May;
109(5):1068-75.
PMID: 17470584
Objective: To assess symptom ratings on the first day of menses to identify women at high risk of clinically significant premenstrual syndrome (PMS) who should undergo further evaluation. Methods: A...
3.
Dean B, Borenstein J, Knight K, Yonkers K
J Womens Health (Larchmt)
. 2006 Jun;
15(5):546-55.
PMID: 16796482
Objective: Criteria for defining premenstrual syndrome (PMS) were assessed by comparing a reference definition previously demonstrated to be associated with reduced health-related quality of life and impaired productivity with alternative...
4.
Dean B, Borenstein J
J Occup Environ Med
. 2004 Jul;
46(7):649-56.
PMID: 15247803
Our objective was to assess life domain and work-related impairment in patients experiencing premenstrual syndrome (PMS). A sample of women, 18 to 45 years of age, completed the Daily Rating...
5.
Dean B, Borenstein J, Henning J, Knight K, Merz C
Am Heart J
. 2004 Jun;
147(6):966-76.
PMID: 15199342
Background: The cardiovascular risk reduction observed in many trials of lipid-lowering agents is greater than expected on the basis of observed low-density lipoprotein cholesterol (LDL-C) level reductions. Our objective was...
6.
Borenstein J, Dean B, Endicott J, Wong J, Brown C, Dickerson V, et al.
J Reprod Med
. 2003 Sep;
48(7):515-24.
PMID: 12953326
Objective: To explore the effect of the premenstrual syndrome (PMS) on health-related quality of life, health care utilization and occupational functioning. Study Design: A cross-sectional cohort study of women prospectively...
7.
Borenstein J, Graber G, Saltiel E, Wallace J, Ryu S, Archi J, et al.
Pharmacotherapy
. 2003 Feb;
23(2):209-16.
PMID: 12587810
Objective: To compare the effectiveness of an evidence-based, systematic approach to hypertension care involving comanagement of patients by primary care physicians and clinical pharmacists versus usual care in reducing blood...